1. Academic Validation
  2. Targeting androgen receptor phase separation to overcome antiandrogen resistance

Targeting androgen receptor phase separation to overcome antiandrogen resistance

  • Nat Chem Biol. 2022 Dec;18(12):1341-1350. doi: 10.1038/s41589-022-01151-y.
Jingjing Xie # 1 2 Hao He # 2 Wenna Kong 1 2 Ziwen Li 1 Zhenting Gao 2 Daoqing Xie 2 Lin Sun 1 2 Xiaofei Fan 2 Xiangqing Jiang 2 Qiangang Zheng 2 Guo Li 2 Jidong Zhu 3 Guangya Zhu 4 5
Affiliations

Affiliations

  • 1 Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
  • 2 Etern Biopharma, Shanghai, China.
  • 3 Etern Biopharma, Shanghai, China. zhujidong@eternbio.com.
  • 4 Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China. zhugy@sioc.ac.cn.
  • 5 Lingang Laboratory, Shanghai, China. zhugy@sioc.ac.cn.
  • # Contributed equally.
Abstract

Patients with castration-resistant prostate Cancer inevitably acquire resistance to antiandrogen therapies in part because of Androgen Receptor (AR) mutations or splice variants enabling restored AR signaling. Here we show that ligand-activated AR can form transcriptionally active condensates. Both structured and unstructured regions of AR contribute to the effective phase separation of AR and disordered N-terminal domain plays a predominant role. AR liquid-liquid phase separation behaviors faithfully report transcriptional activity and antiandrogen efficacy. Antiandrogens can promote phase separation and transcriptional activity of AR-resistant mutants in a ligand-independent manner. We conducted a phase-separation-based phenotypic screen and identified ET516 that specifically disrupts AR condensates, effectively suppresses AR transcriptional activity and inhibits the proliferation and tumor growth of prostate Cancer cells expressing AR-resistant mutants. Our results demonstrate liquid-liquid phase separation as an emerging mechanism underlying drug resistance and show that targeting phase separation may provide a feasible approach for drug discovery.

Figures
Products